{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:46:15Z","timestamp":1760384775469},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1157\/13112366","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T15:45:36Z","timestamp":1196783136000},"page":"375-384","source":"Crossref","is-referenced-by-count":9,"title":["Efectividad del 123I-ioflupano (DaTSCAN\u00a9) en el diagn\u00f3stico de s\u00edndromes parkinsonianos. Una revisi\u00f3n sistem\u00e1tica"],"prefix":"10.1016","volume":"26","author":[{"given":"J.","family":"Pu\u00f1al Riob\u00f3o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Varela Lema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Serena Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruano-Ravina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13112366_bib1","series-title":"Clinical and Research Aspects.","article-title":"Atypical Parkinsonian Disorders","year":"2005"},{"key":"10.1157\/13112366_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1157\/13059042","article-title":"Differential diagnosis of parkinsonism using dopamine transporters brain SPECT","volume":"122","author":"Lorenzo Bosquet","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13112366_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1157\/13112366_bib4","unstructured":"DeLong MR, Juncos JL. Enfermedad de Parkinson y otros trastornos del movimiento. En: Kasper DL, Braunwald E, Fauci AS, et al, editores. Harrison. Principios de Medicina Interna. 16.\u00aa ed. McGraw-Hill Interamericana. Harrison on line 2006; cap\u00edtulo 351."},{"key":"10.1157\/13112366_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of demencia with Lewy bodies","volume":"61","author":"O\u2019Brien","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1157\/13112366_bib6","unstructured":"Ruano Ravi\u00f1a A. Eficacia y seguridad del 123I-ioflupano (DaTSCAN) en el diagn\u00f3stico de s\u00edndromes parkinsonianos. Actualizaci\u00f3n. Serie de Avaliaci\u00f3n de Tecnolox\u00edas. Informes t\u00e9cnicos, Santiago de Compostela, Conseller\u00eda de Sanidade, Axencia de Avaliaci\u00f3n de Tecnoloxias Sanitarias de Galicia, avalia-t; 2005. Report No.: CT2005\/04."},{"key":"10.1157\/13112366_bib7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-005-0401-6","article-title":"Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome","volume":"113","author":"Hesse","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1157\/13112366_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.mnm.0000202858.45522.df","article-title":"I-123-FP-ClT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study","volume":"27","author":"Filippi","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1157\/13112366_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00259-005-1904-y","article-title":"Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease","volume":"33","author":"Eshuis","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1157\/13112366_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.mnm.0000243374.11260.5b","article-title":"Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging","volume":"27","author":"Marshall","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1157\/13112366_bib11","first-page":"31","article-title":"The brain scintiscan with iodine-123-ioflupane to diagnose early Parkinson's disease; seven months follow up. First results in Bulgaria","volume":"9","author":"Piperkova","year":"2006","journal-title":"Hell J Nucl Med"},{"key":"10.1157\/13112366_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0212-6982(05)74184-7","article-title":"Spect con ioflupano I-123 en la catalogaci\u00f3n de pacientes con s\u00edndrome parkinsoniano y vasculopat\u00eda cerebral","volume":"24","author":"Garcia Vicente","year":"2005","journal-title":"Rev Esp Med Nucl"},{"key":"10.1157\/13112366_bib13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s00259-005-1922-9","article-title":"The effect of levodopa therapy on dopamine transporter SPECT imaging with I-123-FP-CIT in patients with Parkinson's disease","volume":"32","author":"Schillaci","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1157\/13112366_bib14","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00259-005-1830-z","article-title":"Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using (123)I-FP-CIT SPECT","volume":"32","author":"Colloby","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1157\/13112366_bib15","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1212\/01.wnl.0000188821.51055.52","article-title":"Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers","volume":"65","author":"Ceravolo","year":"2005","journal-title":"Neurology"},{"key":"10.1157\/13112366_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.crad.2006.10.013","article-title":"Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders","volume":"62","author":"Manoharan","year":"2007","journal-title":"Clin Radiol"},{"key":"10.1157\/13112366_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2006.110122","article-title":"Dementia with lewy bodies: A comparison of clinical diagnosis, FP-CIT SPECT imaging and autopsy","author":"Walker","year":"2007","journal-title":"J Neurol Neurosurg Psyquiatry"},{"key":"10.1157\/13112366_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00702-004-0140-0","article-title":"Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: Evidence from a dopamine transporter imaging study","volume":"111","author":"Ceravolo","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1157\/13112366_bib19","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"Suppl 2","key":"10.1157\/13112366_bib20","first-page":"S247","article-title":"Assessment of 123I-Ioflupane (DaTSCAN TM) diagnostic accuracy by a two year follow-up study of patients with clinically uncertain parkinsonism","volume":"31","author":"Vander Borght","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1157\/13112366_bib21","unstructured":"Grosset D. General Electric Healthcare Symposium Annual Congress, European Association of Nuclear Medicine. Helsinki, Finlandia, September 4-8, 2004."},{"key":"10.1157\/13112366_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410410312","article-title":"Pathological correlates of extrapyramidal signs in Alzheimer's disease","volume":"41","author":"Liu","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1157\/13112366_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archneur.1991.00530180075020","article-title":"Neuropathologic and neurochemical correlates of psychosis in primary dementia","volume":"48","author":"Zubenko","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1157\/13112366_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0893-133X(98)00044-X","article-title":"Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease","volume":"19","author":"Joyce","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1157\/13112366_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0404.1985.tb03186.x","article-title":"Progressive supranuclear palsy 20 years later","volume":"71","author":"Kristensen","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1157\/13112366_bib26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.38.7.1031","article-title":"Prevalence and natural history of progressive supranuclear palsy (Steel-Richardson-Olszewski syndrome)","volume":"38","author":"Golbe","year":"1988","journal-title":"Neurology"},{"key":"10.1157\/13112366_bib27","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.46.4.922","article-title":"Accuracy of clinical criterian for the diagnosis of progressive palsy (Steele-Richardson-Olszewski syndrome)","volume":"46","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1157\/13112366_bib28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmstead County, Minnesota, 1976 to 1990","volume":"49","author":"Hower","year":"1997","journal-title":"Neurology"},{"key":"10.1157\/13112366_bib29","first-page":"1196","article-title":"Iodine-123IBF SPECT evaluation of extrapyramidal diseases","volume":"36","author":"Buck","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1157\/13112366_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","article-title":"Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients","volume":"112","author":"Plotkin","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1157\/13112366_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.40.6.897","article-title":"Parkinsonism due to a basal ganglia lacunar state: Clinicopathologic correlation","volume":"40","author":"Murrow","year":"1990","journal-title":"Neurol"},{"key":"10.1157\/13112366_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000110367","article-title":"Basal ganglia lacunes and parkinsonism","volume":"13","author":"Inzelberg","year":"1994","journal-title":"Neuroepidemiology"},{"key":"10.1157\/13112366_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1468-1331.2003.00748.x","article-title":"The effect of vascular disease on late onset Parkinson's disease","volume":"11","author":"Papapetropoulos","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1157\/13112366_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.STR.28.5.965","article-title":"Neurological signs and frontal white matter lesions in vascular parkinsonism","volume":"28","author":"Yamanouchi","year":"1997","journal-title":"Stroke"},{"key":"10.1157\/13112366_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 4","key":"10.1157\/13112366_bib36","first-page":"IV\/2","article-title":"SPECT and PET imaging of the dopaminergic system in Parkinson's disease","volume":"247","author":"Bruke","year":"2000","journal-title":"J Neurol"},{"key":"10.1157\/13112366_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.10092","article-title":"123 I beta-CIT SPECT distinguishes vascular parkinsonism from parkinson's disease","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov Disord"},{"key":"10.1157\/13112366_bib38","first-page":"57","article-title":"SPECT imaging using [123I] beta-CIT and [123I]IBF in extrapyramidal diseases","volume":"55","author":"Sasaki","year":"2003","journal-title":"No To Shinkei"},{"key":"10.1157\/13112366_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using I-123-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov Disord"},{"key":"10.1157\/13112366_bib40","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/jnnp.2004.045237","article-title":"How useful is [123I]beta-CIT SPECT in clinical practice?","volume":"76","author":"Eerola","year":"2005","journal-title":"J Neurol Neurosurg Psyquiatry"},{"key":"10.1157\/13112366_bib41","first-page":"1812","article-title":"Effects of age on dopamine transporters in healthy humans","volume":"40","author":"Mozley","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1157\/13112366_bib42","first-page":"554","article-title":"Dopamine transporters decrease with age","volume":"37","author":"Volkow","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1157\/13112366_bib43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.56.11.1559","article-title":"Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD","volume":"56","author":"Guttman","year":"2001","journal-title":"Neurology"},{"key":"10.1157\/13112366_bib44","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneur.61.7.1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial","volume":"61","author":"Holloway","year":"2004","journal-title":"Arch Neurol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698207753430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698207753430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T06:50:37Z","timestamp":1546411837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698207753430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0212698207753430"],"URL":"https:\/\/doi.org\/10.1157\/13112366","relation":{},"ISSN":["0212-6982"],"issn-type":[{"value":"0212-6982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}